查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655502

全球生物分解性支架市场

Biodegradable Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计 2030 年全球生物分解性支架市场规模将达 272 亿美元

2024 年全球生物分解性支架市场规模估计为 45 亿美元，预计到 2030 年将达到 272 亿美元，2024-2030 年分析期间的复合年增长率为 35.0%。冠状动脉支架是报告中分析的细分市场，预计其复合年增长率为 34.9%，到分析期结束时市场规模将达到 156 亿美元。预计分析期内週边动脉支架部分的复合年增长率为 35.2%。

美国市场规模估计为 11 亿美元，中国市场预估年复合成长率为 42.8%

预计 2024 年美国生物分解性支架市场价值将达 11 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 85 亿美元，2024-2030 年分析期间的复合年增长率为 42.8%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 26.8% 和 30.7%。在欧洲，德国的复合年增长率预计为 28.8%。

全球生物分解性支架市场 - 主要趋势与驱动因素摘要

为什么生物分解性支架能够彻底改变心血管照护？

生物分解性支架（也称为生物可吸收支架）透过提供临时的动脉支撑，正在改变心血管护理的模式。与无限期留在体内的传统金属支架不同，生物分解性支架会随着时间推移而溶解，从而降低了支架内血管再阻塞和血栓症等长期併发症的风险。心血管疾病仍然是全世界发病率和死亡率的主要原因，开发一种不仅可以恢復血流而且可以在体内安全降解的支架代表着医疗技术的重大进步。对于需要长期副作用较少的微创治疗的患者来说，这项创新至关重要。

生物分解性支架材料的最新创新有哪些？

生物分解性支架新材料的开发是医疗设备製造商关注的重点领域。早期的生物分解性支架由聚乳酸（PLA）等材料製成，但对更先进的聚合物和镁基合金等金属化合物的研究为提高性能开闢了新的可能性。这些新材料具有更高的机械强度、灵活性和可控的降解速率，能够根据个别患者的需求客製化解决方案。此外，表面涂层的进步提高了生物相容性并减少了炎症，使得这些支架在管理长期心血管健康方面更有效。

生物分解性支架在心臟病学以外的用途有哪些？

生物分解性支架最初是为心臟病学开发的，但其用途正在扩展到其他医学学科，包括胃肠病学、泌尿系统和整形外科。在胃肠外科手术中，生物分解性支架用于治疗食道狭窄等病症，在泌尿系统中，可生物降解支架可为泌尿道提供暂时支撑。向新医疗领域的扩展凸显了生物分解性支架技术的多功能性，使其成为广泛专业领域微创手术的重要工具。这些支架在达到其目的后可以溶解，这对于需要临时支架但不想永久植入的患者来说是革命性的。

生物分解性支架的广泛应用面临哪些挑战？

儘管生物分解性支架具有诸多优点，但它也面临一些可能限制其广泛应用的挑战。主要关注点之一是需要长期临床资料来证明其与传统支架相比的有效性。儘管该技术在临床试验中已显示出良好的前景，但由于担心机械完整性和过早劣化，一些医疗相关人员仍然犹豫不决。此外，与传统支架相比，生物分解性支架的成本较高，这可能会成为成本敏感的医疗保健市场的障碍。透过持续的研究和开发解决这些问题对于充分发挥这项创新技术的潜力至关重要。生物分解性支架市场的成长受到多种因素的推动，例如心血管疾病盛行率的上升、生物材料技术的进步以及对微创手术的需求不断增长。随着患者偏好转向最大限度减少异物滞留的治疗方法，生物分解性支架提供了一个有希望的解决方案。证明这些设备的安全性和有效性的监管部门核准和临床试验也在推动市场成长。此外，生物分解性支架在非心臟应用中的使用日益增多，以及易患慢性疾病的老年人口不断增加，进一步促进了对这些创新医疗设备的需求不断增长。

部分

最终用途（医院、心臟中心）；材料类型（聚合物基、金属基）；支架类型（冠状动脉支架、週边动脉支架）

受访公司范例（46家值得关注的公司）

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Sahajanand Medical Technologies Pvt., Ltd.
  • Terumo Europe NV

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP16208

Global Biodegradable Stents Market to Reach US$27.2 Billion by 2030

The global market for Biodegradable Stents estimated at US$4.5 Billion in the year 2024, is expected to reach US$27.2 Billion by 2030, growing at a CAGR of 35.0% over the analysis period 2024-2030. Coronary Artery Stents, one of the segments analyzed in the report, is expected to record a 34.9% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the Peripheral Artery Stents segment is estimated at 35.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 42.8% CAGR

The Biodegradable Stents market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.5 Billion by the year 2030 trailing a CAGR of 42.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 26.8% and 30.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.8% CAGR.

Global Biodegradable Stents Market - Key Trends & Drivers Summarized

Why Are Biodegradable Stents Revolutionizing Cardiovascular Care?

Biodegradable stents, also known as bioresorbable stents, are transforming the landscape of cardiovascular treatment by offering a temporary scaffold for arterial support. Unlike traditional metal stents, which remain in the body indefinitely, biodegradable stents dissolve over time, reducing the risk of long-term complications such as in-stent restenosis and thrombosis. As cardiovascular diseases continue to be a leading cause of morbidity and mortality globally, the development of stents that not only restore blood flow but also degrade safely within the body is a major advancement in medical technology. This innovation is crucial for patients requiring minimally invasive treatments with reduced long-term side effects.

What Are the Latest Innovations in Biodegradable Stent Materials?

The development of new materials for biodegradable stents is a major area of focus for medical device manufacturers. Early biodegradable stents were made from materials like polylactic acid (PLA), but research into more advanced polymers and metallic compounds, such as magnesium-based alloys, has opened new possibilities for improved performance. These newer materials offer better mechanical strength, flexibility, and controlled degradation rates, allowing for more tailored solutions to individual patient needs. Moreover, advances in surface coatings are helping to enhance biocompatibility and reduce inflammation, making these stents more effective in the long-term management of cardiovascular health.

How Are Biodegradable Stents Expanding Beyond Cardiology?

While biodegradable stents were initially developed for cardiology applications, their use is expanding into other areas of medicine, such as gastroenterology, urology, and orthopedics. In gastrointestinal procedures, biodegradable stents are used to treat conditions like esophageal strictures, while in urology, they can provide temporary support in the urinary tract. This expansion into new medical fields underscores the versatility of biodegradable stent technology, making it an essential tool in minimally invasive procedures across a broad range of specialties. The ability of these stents to dissolve after serving their purpose is a game-changer for patients who require temporary scaffolding but do not want permanent implants.

What Are the Challenges in Widespread Adoption of Biodegradable Stents?

Despite their advantages, biodegradable stents face several challenges that could limit their widespread adoption. One of the primary concerns is the need for longer-term clinical data to prove their efficacy over traditional stents. While the technology has shown promise in clinical trials, there is still hesitation among some medical professionals due to concerns over mechanical integrity and premature degradation. Furthermore, the high cost of biodegradable stents compared to conventional stents can be a barrier in cost-sensitive healthcare markets. Addressing these concerns through continued research and development is essential to unlock the full potential of this innovative technology. The growth in the biodegradable stents market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in biomaterial technologies, and the growing demand for minimally invasive procedures. As patient preferences shift toward treatments that minimize foreign body retention, biodegradable stents offer a promising solution. Regulatory approvals and clinical trials demonstrating the safety and efficacy of these devices are also propelling market growth. Additionally, the expanding use of biodegradable stents in non-cardiac applications and the rising geriatric population, who are more prone to chronic diseases, are further contributing to the increased demand for these innovative medical devices.

SCOPE OF STUDY:

The report analyzes the Biodegradable Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Cardiac Centers); Material Type (Polymer Based, Metal Based); Stent Type (Coronary Artery Stents, Peripheral Artery Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Sahajanand Medical Technologies Pvt., Ltd.
  • Terumo Europe NV

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Biodegradable Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Driving Demand for Biodegradable Stents
    • Technological Advancements in Biodegradable Materials and Drug Elution
    • Growing Preference for Minimally Invasive Surgeries in Cardiology
    • Expanding Applications of Biodegradable Stents in Non-Cardiac Treatments
    • Increased Focus on Patient Safety and Reduction of Long-Term Complications
    • Regulatory Approvals Boosting Market Entry of Innovative Stents
    • Emerging Research on Bioabsorbable Polymers Enhancing Stent Performance
    • Impact of Aging Population and Rise in Lifestyle-Related Diseases
    • Rising Healthcare Expenditure in Developing Markets Fueling Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biodegradable Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Coronary Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Coronary Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Peripheral Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Peripheral Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Polymer Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Polymer Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Metal Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Metal Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • JAPAN
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • CHINA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • EUROPE
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • FRANCE
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • GERMANY
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • SPAIN
    • TABLE 72: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Spain 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 76: Spain Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Spain 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • RUSSIA
    • TABLE 78: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Russia 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 82: Russia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Russia 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • AUSTRALIA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 98: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Australia 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 100: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Australia 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 102: Australia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Australia 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • INDIA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 104: India Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: India 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 106: India Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: India 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 108: India Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: India 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 110: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: South Korea 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 112: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: South Korea 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 114: South Korea Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: South Korea 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 116: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Asia-Pacific 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 118: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Asia-Pacific 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 120: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • LATIN AMERICA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 122: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 123: Latin America 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 124: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Latin America 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 126: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Latin America 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 130: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Argentina 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 132: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Argentina 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • BRAZIL
    • TABLE 136: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Brazil 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 138: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Brazil 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • MEXICO
    • TABLE 142: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Mexico 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 144: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Mexico 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 148: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of Latin America 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 150: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of Latin America 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • MIDDLE EAST
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 154: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 155: Middle East 6-Year Perspective for Biodegradable Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 156: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Middle East 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 160: Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Middle East 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • IRAN
    • TABLE 162: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 163: Iran 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 164: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Iran 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 166: Iran Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Iran 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • ISRAEL
    • TABLE 168: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Israel 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 170: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Israel 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 172: Israel Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Israel 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 174: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Saudi Arabia 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 176: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Saudi Arabia 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 178: Saudi Arabia Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Saudi Arabia 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 180: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 181: UAE 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 182: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: UAE 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 184: UAE Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 185: UAE 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 186: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Rest of Middle East 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 188: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Middle East 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 190: Rest of Middle East Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 191: Rest of Middle East 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030
  • AFRICA
    • Biodegradable Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 192: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by Stent Type - Coronary Artery Stents and Peripheral Artery Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 193: Africa 6-Year Perspective for Biodegradable Stents by Stent Type - Percentage Breakdown of Value Sales for Coronary Artery Stents and Peripheral Artery Stents for the Years 2025 & 2030
    • TABLE 194: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by Material Type - Polymer Based and Metal Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Africa 6-Year Perspective for Biodegradable Stents by Material Type - Percentage Breakdown of Value Sales for Polymer Based and Metal Based for the Years 2025 & 2030
    • TABLE 196: Africa Recent Past, Current & Future Analysis for Biodegradable Stents by End-Use - Hospitals and Cardiac Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Africa 6-Year Perspective for Biodegradable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiac Centers for the Years 2025 & 2030

IV. COMPETITION